Liver Decompensation after Bariatric Surgery in the Absence of Cirrhosis
- PMID: 35138516
- DOI: 10.1007/s11695-022-05930-3
Liver Decompensation after Bariatric Surgery in the Absence of Cirrhosis
Abstract
Purpose: Metabolic dysfunction-associated fatty liver disease-related cirrhosis is possible at the time of bariatric surgery, complicated by further liver decompensation. Hepatic decompensation can also occur in the absence of cirrhosis but the presentation is less clear.
Methods: We analyze the clinical characteristics, histological findings, and management of patients without cirrhosis who developed hepatic decompensation after bariatric surgery in our single tertiary-care hospital.
Results: From 2014 to 2019, 6 patients underwent a transvenous liver biopsy for liver decompensation after bariatric surgery. Mean age at diagnosis was 44 years. The time between bariatric surgery and the onset of symptoms varied widely (min. 8 months, max. 17 years). Mean % of weight loss was high at 43%. The clinical presentation was as follows: fatigue and jaundice (5/6), leg edema (3/6), and ascites (1/6). Blood test showed increased transaminases (mean ALT 53 UI/L, mean AST 130 UI/L), bilirubin (mean 6 mg/dL), and INR (mean 1.5) with a low albumin level (mean 27 mg/dL). The hepatic venous pressure gradient was high (mean 10 mmHg). Histology revealed steatosis, hepatocyte ballooning but also portal inflammation with polymorphonuclear cells, and bile duct alterations. Mean fibrosis score was 2. The clinical course was favorable with nutritional support with a mean follow-up of 36 months.
Conclusion: Liver decompensation in the absence of cirrhosis can occur after bariatric surgery with a highly variable delay. A special histological signature is present with the coexistence of steatosis, bile duct alterations, and portal inflammation. Substantial clinical improvement with appropriate nutritional support seems to be effective.
Keywords: Bariatric surgery; Cholestasis; Fatty liver; Liver failure.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.Surg Obes Relat Dis. 2018 Jan;14(1):81-91. doi: 10.1016/j.soard.2017.09.005. Epub 2017 Sep 11. Surg Obes Relat Dis. 2018. PMID: 29126863
-
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392. Obes Surg. 2006. PMID: 17217634
-
Outcomes of Bariatric Surgery in Patients with Cirrhosis.Obes Surg. 2019 Feb;29(2):585-592. doi: 10.1007/s11695-018-3562-8. Obes Surg. 2019. PMID: 30397876
-
Bariatric surgery in individuals with liver cirrhosis: A narrative review.Rev Assoc Med Bras (1992). 2017 Feb;63(2):190-194. doi: 10.1590/1806-9282.63.02.190. Rev Assoc Med Bras (1992). 2017. PMID: 28355381 Review.
-
Considerations for bariatric surgery in patients with cirrhosis.World J Gastroenterol. 2018 Jul 28;24(28):3112-3119. doi: 10.3748/wjg.v24.i28.3112. World J Gastroenterol. 2018. PMID: 30065557 Free PMC article. Review.
Cited by
-
Higher Pre-Operative Non-Invasive Fibrosis Scores are not Associated with Surgical Outcomes in Patients with MASLD Undergoing Metabolic and Bariatric Surgery.Can Liver J. 2025 Feb 12;8(2):284-289. doi: 10.3138/canlivj-2024-0015. eCollection 2025 May. Can Liver J. 2025. PMID: 40677984 Free PMC article.
-
Are elevated systemic bile acids involved in the pathophysiology of sarcopenia and liver injury following gastric bypass?Acta Gastroenterol Belg. 2023 Apr-Jun;86(2):377-381. doi: 10.51821/86.2.11517. Acta Gastroenterol Belg. 2023. PMID: 37428176 Free PMC article.
-
Post-Metabolic Bariatric Surgery Cirrhosis and the Role of Liver Transplantation: A Report from a Referral Transplant Center.Obes Surg. 2025 Jun;35(6):2111-2120. doi: 10.1007/s11695-025-07852-2. Epub 2025 May 9. Obes Surg. 2025. PMID: 40343656
-
Sleeve-gastrectomy results in improved metabolism and a massive stress response of the liver proteome in a mouse model of metabolic dysfunction-associated steatohepatitis.Heliyon. 2024 Sep 28;10(21):e38678. doi: 10.1016/j.heliyon.2024.e38678. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39524892 Free PMC article.
References
-
- Kinlen D, Cody D, O’Shea D. Complications of obesity. QJM. 2018:437–43.
-
- Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:1495–7.
-
- Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc. 2004:1724–37.
-
- Lassailly G, Caïazzo R, Pattou F, et al. Bariatric surgery for curing NASH in the morbidly obese? J Hepatol. 2013:1249–51.
-
- La LN. NASH en 2018. Louv Med. 2018;137:308–13.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical